Autres langues Compugen Ltd.

Actions

CGEN

IL0010852080

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
2,16 ^USD	+8,54%		+13,68%	+9,09%

08/03	COMPUGEN LTD. : Truist Securities optimiste sur le dossier	ZM
05/03	Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024	26/04
Compugen : To Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024	25/04
Compugen to Participate in Two Upcoming Investor Conferences	03/04
Compugen : Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy	11/03
Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy	11/03
Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024	07/03
Compugen : To Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024	06/03
Compugen: Q4 Earnings Snapshot	05/03
Earnings Flash (CGEN) COMPUGEN Reports Q4 Revenue $33.5M	05/03
Earnings Flash (CGEN) COMPUGEN Posts Q4 EPS $0.11	05/03
Compugen : Form 6-K- Fourth quarter and full year 2023 results	05/03
Earnings Flash (CW9) COMPUGEN Posts Q4 EPS $0.11	05/03
Compugen Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	05/03
Compugen Reports Fourth Quarter and Full Year 2023 Results	05/03
Compugen to Present at the Leerink Partners Global Biopharma Conference 2024	26/02
Compugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024	20/02
Compugen names new chief medical officer	16/02
Compugen Ltd. Announces Executive Changes	15/02
Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer	15/02
Sector Update: Health Care Stocks Stronger Late Afternoon	19/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Compugen Ltd.

Actions

CGEN

IL0010852080

Autres langues

Filtres